Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Phase III Trial of Cisplatin and Tumor Volume Directed Irradiation Followed by Carboplatin and Paclitaxel vs. Carboplatin and Paclitaxel for Optimally Debulked, Advanced Endometrial Carcinoma

NCT00942357 is registered in ClinicalTrials.gov with Gynecologic Oncology Group as lead sponsor.

NCT NCT00942357
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00942357 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Phase III Trial of Cisplatin and Tumor Volume Directed Irradiation Followed by Carboplatin and Paclitaxel vs. Carboplatin and Paclitaxel for Optimally Debulked, Advanced Endometrial Carcinoma
Lead sponsor
Gynecologic Oncology Group
Phase
Phase 3
Overall status
Unknown status
Start date
June 29, 2009
Completion date
July 28, 2024
Enrollment
813 (actual)
Sites
670

Conditions

As the registry lists them; a condition with its own page is linked.

endometrial clear cell adenocarcinoma, endometrial serous adenocarcinoma, stage ia uterine corpus cancer ajcc v7, stage ib uterine corpus cancer ajcc v7, stage ii uterine corpus cancer ajcc v7, stage iiia uterine corpus cancer ajcc v7, stage iiib uterine corpus cancer ajcc v7, stage iiic uterine corpus cancer ajcc v7, stage iva uterine corpus cancer ajcc v7